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Abstract 
Differentiation between photoallergenic and phototoxic reactions induced by low molecular weight 
compounds represents a current problem. The use of keratinocytes as a potential tool for the detection of 
photoallergens as opposed to photoirritants is considered an interesting strategy for developing in vitro 
methods. We have previously demonstrated the possibility to use the human keratinocyte cell line 
NCTC2455 and the production of interleukin-18 (IL-18) to screen low molecular weight sensitizers. The 
purpose of this work was to explore the possibility to use the NCTC2544 assay to identify photoallergens and 
discriminate from phototoxic chemicals.  
First, we identified suitable condition of UV-irradiation (3.5 J/cm
2
) by investigating the effect of UVA-
irradiation on intracellular IL-18 on untreated or chloropromazine (a representative phototoxic compound)-
treated NCTC2544 cells. Then, the effect of UVA-irradiation over NCTC2544 cells treated with increasing 
concentrations of 15 compounds including photoallergens (benzophenone, 4-ter-butyl-4-methoxy-
dibenzoylmethane, 2-ethylexyl-p-methoxycinnamate, ketoprofen, 6-methylcumarin); photoirritant and 
photoallergen (4-aminobenzoic acid, chlorpromazine, promethazine); photoirritants (acridine, ibuprofen, 8-
methoxypsoralen, retinoic acid); and negative compounds (lactic acid, SDS and p-phenilendiamine) was 
investigated. Twenty-four hours after exposure, cytotoxicity was evaluated by the MTT assay or LDH 
leakage, while ELISA was used to measure the production of IL-18. At the maximal concentration assayed 
with non-cytotoxic effects (CV80 under irradiated condition), all tested photoallergens induced a significant 
and a dose-dependent increase of intracellular IL-18 following UVA irratiation, whereas photoirritants failed. 
We suggest that this system may be useful for the in vitro evaluation of the photoallergic potential of 
chemicals.  
 
Keywords: photosensitization, UVA, NCTC2544, IL-18, in vitro, phototoxicity 
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1. Introduction 
Safety evaluation of ingredients is an important part of the development of cosmetics and drugs. 
Phototoxicity, photoirritation and photoallergy are health hazards arising from exposure of skin to normally 
harmless levels of light in the presence of radiation-absorbing compounds. The growing use of cosmetics in 
combination with relative high UV-light exposure potentiates this problem. Photoactivation and binding of 
photoactive compounds to proteins is a known prerequisite for the formation of immunogenic photoantigens 
and the induction of photoallergy. Ultraviolet A (UVA) is the action spectrum of this photoderivatization, as 
protein and cells are photocoupled with photohaptenic compounds by irradiation with UVA but not UVB 
(Tokura, 2000; Tokura, 2005). Photochemiotoxic reactions may be phototoxic or photoallergic in nature. 
Acute phototoxic reactions are generally characterized by erythema and oedema followed by 
hyperpigmentation and desquamation. Chronic repeated injury of this type may result in fragility, blistering 
and milia formation or even actinic keratoses and skin cancers. The photochemical mechanisms involved 
may differ. They include photoaddition of the chemical to biological targets such as DNA, the formation of 
toxic products due to absorption of light by the phototoxic molecule, the generation of reactive oxygen 
species or free radicals (Epstein and Wintroub, 1985). Phototoxic reactions are significantly more common 
than photoallergic reactions and mostly resemble to exaggerated sunburns. Photoallergic reactions appear 
only in a minority of individuals and resemble allergic contact dermatitis on sun-exposed areas, although 
sometimes may extend into covered areas. Generally, the physical examination and a positive patient's 
history of photosensitivity reactions on substances are of great importance for the diagnostics. Photocontact 
allergic dermatitis is one of the undesirable adverse effects produced by chemicals and drugs in our 
environment (Yamamoto and Tokura, 2003), it is a delayed type IV hypersensitivity reaction seen when an 
exogenous agent comes into contact with the skin in the presence of UV. Various chemicals have been 
reported to cause photocontact dermatitis. The physical manifestation of this increased photosensitivity will 
depend on the specific photosensitizer; some will reduce the threshold to sunburn while others may induce a 
photoallergy in susceptible individuals (Maverakis et al., 2010). Historically, the use of halogenated 
salicylanilide and related compounds, especially 3,3′,4′,5-tetrachlorosalicylanilide and bithionol, resulted in a 
large number of patients with this skin disease. More recent causative agents include cosmetic or sunscreen 
products such as 6-methylcoumarin, musk ambrette, benzophenone. Likewise, there have been various 
culprit drugs to evoke photosensitivity, including chlorpromazine, promethazine, quinolones, such as 
sparfloxacin and enoxacin, piroxicum, afloqualone, and non-steroidal anti-inflammatory drugs (Kurita et al., 
2007). 
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Assessments of phototoxic properties of ingredients have generally been performed using animal tests 
including Guinea pigs, rabbits, rats and mice (Maurer et al., 1980; Jordan, 1982; Gerberick and Ryan, 1990; 
Ulrich et al., 1998). However, the development of alternative in vitro assays is now required following the 7
th
 
amendment of the European Cosmetics Directive (Directive 76/768/EEC), which aims for the complete 
replacement of animal testing by 2013. For phototoxicity testing, the in vitro 3T3 NRU phototoxicity test has 
been adopted as an alternative to in vivo phototoxicity test (OECD n°432). In vitro replacements for the in 
vivo photoallergy test have also been sought (Tokura, 2000; Lovell and Jones, 2000; Barratt et al., 2000; 
Neumann et al., 2005; Onoue and Tsuda, 2005; Kurita et al., 2007, Hoya et al., 2009; Karschk et al., 2010), 
but to date no accepted alternative is available to identify the photoallergenic potential of new chemicals.  
We recently shown that exposure of the human keratinocyte cell lines NCTC2544, HaCaT or primary 
keratinocytes to contact allergens, but not to respiratory allergens or irritants, resulted in a dose-related 
induction of intracellular IL-18. The NCTC 2544 assay was developed within the SENS-IT-IV project 
sponsored by the European Union. The assay proved to be useful in the identification and discrimination of 
contact allergens from respiratory sensitizers and irritants (Corsini et al., 2009; Galbiati et al., 2011). IL-18 
was chosen as this cytokine, formerly known as IFN-γ-inducing factor (IGIF), which belongs to the IL-1 
cytokine family, has been shown to play a key proximal role in the induction of allergic contact sensitization 
and to favour Th-1 type immune response by enhancing the secretion of pro-inflammatory mediators such as 
TNF-α, IL-8 and IFN-γ, (Okamura et al., 1995; Cumberbatch et al., 2001; Antonopoulos et al., 2008). 
The purpose of this work was to explore the possibility to use the current NCTC 2544 IL-18 assay for the 
identification of photosensitizers and discriminate them from phototoxic chemicals, and to develop a new in 
vitro photosensitization test system. 
 
2.  Materials and methods 
2.1. Chemicals 
Phototoxic chemicals were selected based on compounds used in similar published studies (Hoya et al., 
2009; Karschuk et al., 2010) and reported to cause allergic contact dermatitis (Ibbotson et al., 1997), and the 
commercially availability from credited sources. As photosensitizers the following chemicals were used: 
benzophenone, 2-ethylhexyl 4-methoxycinnamate (Parsol MCX), 4-tert-butyl-4'-methoxydibenzoylmethane 
(Avobenzone), 6-methylcoumarin, ketoprofen. As photosensitizers / photoirritants 4-aminobenzoic acid 
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 5 
(PABA), chloropromazine, promethazine, and as photoirritants acridine, ibuprofen, 8-methoxy-psoralen, 
retinoic acid were used. As negative compounds lactic acid, sodium dodecyl sulphate (SDS) and p-
phenylendiamine (PPD) were used. All reagents were purchased from Sigma (St Louis, MO, USA) at the 
highest purity available. All chemicals were dissolved in DMSO (final concentration of DMSO in culture 
medium 0.2%). DMSO (0.2% final concentration) was used as vehicle control. Solutions were freshly 
prepared for each experiment. 
 
2.2. Cell culture, treatment and irradiation conditions 
NCTC 2544 cells (Istituto Zooprofilattico di Brescia, Brescia, Italy) were cultured in RPMI 1640 containing 2 
mM L-glutamine, 0.1 mg/mL streptomycin, 100 IU/mL penicillin, 10 g/ml gentamycin supplemented with 
10% heated-inactivated foetal calf serum (complete medium) and cultured at 37 °C in 5% CO2.  
The irradiation of the cells was carried out in a photostability UV chamber equipped with four UVA lamps 
(lamp potency 0.84 mW/cm
2
; UVA EN-180L/F - Colaver, Vimodrone, Italia). Irradiance was routinely 
measured before cell exposure with a photoradiometer Delta OHM provided with a UVA probe (HD2302 - 
Italy) to determine UV dose using the following equation: 
E (J/cm
2
) = t(s) x P (W/cm
2
) 
where E stands for UV energy, t represents the time expressed in seconds and, finally, P is the lamp 
potency. Cells were irradiated with a dosing of of 3.5-7 J/cm
2
. 
Cells were seeded in 24-well plate or in 96-well plate at a cell density of 2.5 x 10
5
/ml (0.5 ml/well in 24-well 
plate and 0.1 ml/well in 96-well plate). After overnight adherence, cells were irradiated or not irradiated in the 
presence of increasing concentrations of the selected chemicals in PBS (200 μl/well in 24-well plate and 40 
μl/well in 96-well plate). Each concentration was tested in quadruplicate (n= 4 wells). Non-irradiated cells 
were kept in the dark during irradiation. After irradiation, 300 μl or 60 μl of complete medium was added to 
each well. Cells were then incubated for 24 hours.  
 
2.3. Cell viability 
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Prior to study the effects of the selected chemicals on IL-18 production, cytotoxicity was assessed by the 
MTT test (Gerlier and Thomasset, 1986). Cells seeded in a 96-well plate were treated with increasing 
concentrations of the test chemical or DMSO as vehicle control, and exposed to UV light or kept in the dark. 
After irradiation, cells were incubated for 24 h, medium was then discarded and 100 µl/well of MTT solution 
0.75 mg/ml in culture medium was added. Cells were incubated for 3 h at 37 °C, medium was discard and 
cells lysed in 100 µl/well of a mixture of HCl 1 N and isopropanol (1:24). The absorbance of the resulting 
solutions was read at a wavelength of 595 nm in a microplate reader (Molecular Devices). 80 % cell viability 
(CV80) was calculated for each chemical by linear regression analysis of data in both irradiated and non-
irradiated conditions, the average CV80 obtained from two independent experiments was used as the 
highest concentration. 
Cell viability was also assessed by lactate dehydrogenase (LDH) leakage from damaged cells. LDH is a well-
known indicator of cell membrane integrity and cell viability. LDH activity was determined in cell-free 
supernatants using a commercially available kit (Takara Bio Inc., Japan). Results are expressed as OD. 
 
2.4. Cytokine production 
For intracellular IL-18 assessment, after incubation, culture medium was discarded, monolayers gently 
washed once with 1.0 ml of PBS and cells lysed in 0.25 ml of 0.5% Triton X- 100 in PBS. Cell lysates were 
stored at -80 °C until measurement. Intracellular IL-18 content was assessed by specific sandwich ELISA 
commercially available (MBL, Nagoya, Japan). Limit of detection was 15.6 pg/ml. The protein content of the 
cell lysate was measured with the BCA assay. Results are expressed in pg/mg of total intracellular protein 
content, or as ratio between the stimulation index (SI) calculated in irradiated (I) conditions versus the SI in 
non-irradiated (NI) conditions (IL-18 SI I/NI), where the stimulation index is calculated dividing the 
intracellular IL-18 content in treated cells vs intracellular IL-18 in control cells (n= 4 wells). 
 
2.5. Data analysis 
For classification of chemicals, the following PREDICTION MODEL was used: if the IL-18 SI (I/NI) is > 1.3 
and the increase in IL-18 is statistically significant from vehicle treated cells (Dunnett multiple comparisons 
test) the chemical is classified as potential photoallergen. For a given chemical, the same classification must 
be obtained in two out of three independent experiments. The 1.3 fold increase is meant for at least one of 
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 7 
the concentrations tested. The 1.3 induction must be observed at CV > 80%. All experiments with the 
selected chemicals were therefore performed at least three times, and one of the three experiments is shown 
as representative. Data are expressed as mean ± standard deviation (SD), n=4. A 20% variation among 
replicates is considered acceptable. Statistical analysis was performed using InStat software version 3.0a 
(GraphPad Software, La Jolla, CA, USA). Statistical differences were determined using ANOVA followed by 
a multiple comparison test as indicated in the legends. Effects were designated significant if p< 0.05. Data 
obtained from the different experiments are not pooled, as each experiment must be considered 
independently for the classification.  
 
3. Results 
3.1. Establishment of the irradiation conditions 
The dose of UVA irradiation was assessed exposing cells to increasing UVA doses. Under our experimental 
conditions, as shown in Fig. 1 A, the dose of 3.5 J/cm
2
 represents the optimal UVA dose. As at this dose, no 
effects of UVA alone was observed, while UVA dose of 7 J/cm
2
 resulted in a loss of IL-18 production and 
LDH leakage (cytotoxicity), compared to not irradiated cells.  
The photoallergen/photoirritant chloropromazine was then used to establish the optimal irradiation conditions 
in the presence of potential phototoxic compound. Initially, as highest concentration the CV80 calculated in 
non-irradiated condition was used (Fig.1 B, C), hoping to use the same SOPs developed for the NCTC 2544 
IL-18 assay. In this condition, however, following UVA irradiation a dramatic cytotoxicity was observed as 
assessed by LDH leakage, which resulted in the impossibility to assess the effect of irradiated 
chloropromazine on IL-18 production. Therefore, CV80 was assessed in irradiated condition. As shown in 
Fig.1 D, using the CV80 calculated in irradiated condition as the highest concentration, irradiated 
chloropromazine induced a dose-related increase in intracellular IL-18. To appreciate the effect of the 
combination of chemical + UVA, the ratio of IL-18 SI in irradiated vs non-irradiated conditions is reported as 
dotted line (Fig. 1D). 
Based on these experiments, the UVA dose of 3.5 J/cm
2
 was selected, and as highest concentration the 
CV80 calculated in irradiated condition was used.  
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3.2. Determination of 80% cell viability 
The concentration of chemical resulting in 80% of viability (CV80) respect to vehicle treated cells 24 h was 
calculated for all chemicals in both non-irradiated and irradiated conditions. Results are presented in Table 1. 
For many chemicals, including photoallergens and photoirritants, a lower CV80s were observed in irradiated 
condition.  
 
3.3. Selective induction of intracellular IL-18 by photoallergens 
NCTC2544 cells were treated for 24 h with the selected photoallergens (Fig.2), photoallergens/photoirritants 
(Fig. 3), photoirritants (Fig. 4), and non-phototoxic compounds (Fig.5). Following treatment and UVA 
irradiation, the intracellular IL-18 content was assessed as described in the Materials and Methods section. 
Results are reported as the ratio of IL-18 SI in irradiated vs non-irradiated conditions (IL-18 SI (I/NI)).  
As shown in Fig. 2 and Fig. 3, all irradiated photoallergens and photoallergens/photoirritants, induced a 
statistical significant increase in intracellular IL-18, with an IL-18 SI (I/NI) up to 7 for chloropromazine. The 
lowest inductions were observed for avobenzone and benzophenone. In all figures, a dotted line was set at a 
SI of 1.3, as provisional criteria for identification of photoallergens and discriminate them from photoirritants. 
We then tested the effect of the photoirritants ibuprofen, acridine, retinoic acid and 8-methoxypsoralene (Fig. 
5). Irradiated ibuprofen and acridine failed to induced IL-18 production, while a slight increase, below or 
close to IL-18 SI (I/NI) of 1.3, was observed at the highest concentration of 8-methoxypsoralene and retinoic 
acid.  
Finally, we assessed the effects of not phototoxicants, namely PPD, lactic acid and SDS on intracellular IL-
18 production. Following UVA irradiation, none of them was able to increase intracellular IL-18 (Fig. 5), 
confirming the selective up-regulation of IL-18 by irradiated photoallergens. 
 
3.4 Reproducibility of data 
To appreciate the variability among independent experiments performed on different days over one year 
period, we reported in Fig. 6 the IL-18 SI (I/NI) obtained for chloropromazine 1.25 M (15 experiments), 
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 9 
ketoprofen 2.5 M (4 experiments) and 6-methylcoumarin 10 M (5 experiments).  The reason for which we 
tested these chemicals repeatidly was to identify a positive control to be used routinely in the assay. We 
initially tought to use chloropromazine 1.25 M, but due to variability in the SI, we later decided to use 
ketoprofen or 6-methylcoumarin. IL-18 SI (I/NI) for chloropromazine 1.25 M ranged from 1.25 to 7.7 with an 
average of 3.16; for ketoprofen 2.5 M from 1.28 to 1.42 with an average of 1.33, and for 6-methylcoumarin 
10 M from 1.2 to 3.20 with an average of 1.76. As for the NCTC 2544 IL-18 assay (Corsini et al., 2009; 
Galbiati et al., 2011), the differences observed in the absolute value of IL-18 may be due to many factors 
including the number of cells seeded and adhering to plate wells, to the use of a different cell batch, the 
performance of IL-18 ELISA and protein assay as well as to differences in the chemical concentration (fresh 
solutions are used) and slight variation in the irradiation conditions. Despite the variability, the discriminatory 
capacities based on defined prediction model are, however, preserved. 
 
4. Discussion 
Given that there is no in vivo or in vitro methods developed which regulatory authorities to assess 
photosensitization induced by chemicals, in the present work, have adopted we describe the possibility to 
use the NCTC2544 IL-18 assay to identify in vitro photoallergens. We found that irradiated photoallergens 
induced a significant increase in intracellular IL-18 compared to photoirritants or not photoxic compounds. As 
provisional prediction model, based of the tested chemicals, an IL-18 SI (I/NI) > 1.3 was set as criteria for 
identification of photoallergens.  
Due to their anatomical location and critical role in skin inflammatory and immunological reactions, the use of 
keratinocytes and skin organotypic culture as a simplified in vitro model to evaluate the potential toxicity of 
chemicals destined for epicutaneous application is amply justified. In the present work, intracellular IL-18 
was investigated after exposure of NCTC 2544 cells to several photoallergens, and photoirritants. We 
showed that UVA irradiation of NCTC 2544 cells treated with photoallergens results in a dose-related 
induction of intracellular IL-18, indicating the possibility to use IL-18 to specifically identify photoallergens and 
distinguish them from photoirritants.  
As mentioned in the Introduction, IL-18 was chosen, as this cytokine is mainly associated with Th1-mediated 
immune responses. Interestingly, it has been proposed that UV damage can be considered a “danger” 
signal. Recent data linking IL-1β and IL-18 production to “inflammasomes” supports this notion. IL-1β and IL-
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18 are normally expressed in human keratinocytes as an inactive precursor. Upon exposure to UV radiation, 
both precursors are cleaved by caspase-1 to yield active IL-1β and IL-18. Caspase-1 activation is dependent 
upon its recruitment to inflammasomes, which links UV-induced cytokine production to the innate immune 
system. Inflammasomes are composed of NOD-like receptor (NLR)-family proteins (Feldmeyer et al., 2007). 
These intracellular proteins contain a nucleotide-binding oligomerization domain called NACHT and several 
leucine rich repeat domains that may bind to microbial ligands similar to Toll-like receptor family proteins. 
The relationship between inflammasomes and UV-induced IL-1β and IL-18 production demonstrates that this 
pathway can also sense UV-induced tissue injury. Under our experimental condition, the UVA dose used 
alone didn't induce IL-18. Only the combination chemical (photoallergen) + UVA resulted in IL-18 induction. 
However, a similar mechanism of inflammasome activation is likely to be triggered by photoallergens. For 
allergens, we previously demonstrated a role for oxidative stress, NF-κB and p38 MAPK activation in PDD-
induced IL-18 production (Galbiati et al., 2011), consistent with an inhibition of IL-18 transcription as in 5’ 
upstream region of the human IL-18 gene AP-1, PU.1, NF-κB and SP-1 transcription binding sites have been 
identified (Takeuchi et al., 1999). 
A critical initial point in our study was the choice of UVA dose and chemical exposure conditions. Suitable 
irradiation conditions for the test were determined using chloropromazine as a representative photoallergen. 
This drug and several others related phenothiazines are known to cause both phototoxic and photoallergic 
reaction in the skin and eyes of patients. The original SOP developed for the NCTC2544 IL-18 assay had to 
be adapted to the UVA irradiation. A UVA dose of 3.5 J/cm
2
 was chosen, and the CV80 calculated in 
irradiated condition was selected as the highest concentration.  
We then investigated if commercially available photosensitizers could selectively up regulate IL-18 in human 
keratinocytes after UVA exposure. We could indeed demonstrate that compounds classified as 
photosensitizers or photoallergens/photoirritants have the ability to increase IL-18 intracellular levels in a 
dose related-manner, whereas photoirritants failed. A slight increase in IL-18 was observed with 8-
methoxypsoralene and retinoic acid. It is important to mention that both chemicals are reported to possess 
photoallergenic effects. Recent literature and FDA-approved package for all-trans-retinoic acid products 
state explicitly that all-trans-retinoic acid is both a phototoxin and a photosensitizer (Moore, 2002; Fu et al., 
2003; Tolleson et al., 2005; Stein and Scheinfeld, 2007). Even if photoallergy to furocoumarins has rarely 
been reported, Bonamonte et al. (2010) clearly demonstrated photoallergic contact dermatitis to 8-
methoxypsoralen. In the establishment of our prediction model, both compounds were, however, considered 
as photoirritants. Therefore, based on the effect on IL-18 observed for these two chemicals, the cut off of IL-
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18 SI (I/NI) > 1.3 was set to identify and discriminate photoallergens from photoirritants. Based on human 
classification, an overall accuracy of 100 % of the proposed assay was obtained.  
In conclusion, we propose a new reliable in vitro photosensitization assay using the keratinocyte cell line 
NCTC2544 and IL-18 production. The induction of IL-18 following UVA irradiation may represent a promising 
in vitro model for the screening and evaluation of potential photoallergens, reducing the risk of photoallergic 
reactions. Although we need to further confirm the applicability of the test evaluating a wider battery of 
chemicals, we consider that this assay may become a useful cell-based in vitro test for evaluating the 
photosensitizing potential of chemicals.  
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Table 1. Concentration (µM) of the tested chemicals that induced 80% viability (CV80) in non-irradiated and 
irradiated conditions (3.5 J/cm
2
), and their classification. 
Compound CV80 Non-Irradiated CV80 Irradiated Category 
2-ethylhexyl-4-methoxycinnamate 3400 9.8 Photoallergen 
6-methylcoumarin > 1000 10 Photoallergen 
Avobenzone 90 90 Photoallergen 
Benzophenone > 1000 31.2 Photoallergen 
Ketoprofen 3000 4.9 Photoallergen 
    
4-aminobenzoic acid (PABA) 7300 7300 Photoallergen/photoirritant 
Chlorpromazine 20 1.25 Photoallergen/photoirritant 
Promethazine 125 1 Photoallergen/photoirritant 
    
8-methoxypsoralen 700 2 Photoirritant 
Acridine 2116 0.05 Photoirritant 
Ibuprofen > 1000 > 1000 Photoirritant 
Retinoic acid 50 20 Photoirritant 
    
p-phenylenediamine (PPD) 55 27.5 Allergen 
Lactic acid > 8300 > 8300 Irritant 
Sodium dodecyl sulfate (SDS) 100 100 Irritant 
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LEGENDS TO FIGURES 
Figure 1. Effects of UVA irradiation on intracellular IL-18 and viability of NCTC2544 cells. (A) Cells were 
irradiated at the UVA doses of 3.5 and 7 J/cm
2
. Intracellular IL-18 and LDH leakage were assessed 24 h 
later. Results are expressed as mean ± SD, n= 4. Statistical analysis was performed with Dunnett’s multiple 
comparison test, with ** p < 0.01 vs non-irradiated cells (NI). Dose response effects of chloropromazine on 
cell viability (B) and cell-associated IL-18 (C). NCTC2544 cells were irradiated (I) at the UVA dose of 3.5 
J/cm
2 
or non-irradiated (NI) in the presence of increasing concentrations of chloropromazine, using the CV80 
calculated under non-irradiated condition as highest concentration. (D) Dose response effects of 
chloropromazine on cell-associated IL-18, using the CV80 calculated under irradiation condition as highest 
concentrations. Results are expressed as mean ± SD, n= 4. Statistical analysis was performed with 
Dunnett’s multiple comparison test, with * p < 0.05 and ** p < 0.01 vs vehicle treated cells (0). 
 
Figure 2. Effects of the selected photoallergens on cell-associated IL-18. NCTC2544 cells were irradiated (I) 
at the UVA dose of 3.5 J/cm
2 
or non-irradiated (NI) in the presence of increasing concentrations of the 
selected photoallergens, using the CV80 calculated under irradiated condition as highest concentration. 
Results are expressed as IL-18 SI (I/NI). A dotted line was set at a SI of 1.3. Each data is mean ± SD, n= 4. 
Statistical analysis was performed with Dunnett’s multiple comparison test, with * p < 0.05 and ** p < 0.01 vs 
vehicle treated cells. 
 
Figure 3. Effects of the selected photoallergens/photoirritants on cell-associated IL-18. NCTC2544 cells 
were irradiated (I) at the UVA dose of 3.5 J/cm
2 
or non-irradiated (NI) in the presence of increasing 
concentrations of the selected photoallergens/photoirritants, using the CV80 calculated under irradiated 
condition as highest concentration. Results are expressed as IL-18 SI (I/NI). A dotted line was set at a SI of 
1.3. Each data is mean ± SD, n= 4. Statistical analysis was performed with Dunnett’s multiple comparison 
test, with * p < 0.05 and ** p < 0.01 vs vehicle treated cells. 
 
Figure 4. Effects of the selected photoirritants on cell-associated IL-18. NCTC2544 cells were irradiated (I) 
at the UVA dose of 3.5 J/cm
2 
or non-irradiated (NI) in the presence of increasing concentrations of the 
selected photoirritants, using the CV80 calculated under irradiated condition as highest concentration. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 17 
Results are expressed as IL-18 SI (I/NI). A dotted line was set at a SI of 1.3. Each data is mean ± SD, n= 4. 
Statistical analysis was performed with Dunnett’s multiple comparison test, with * p < 0.05 and ** p < 0.01 vs 
vehicle treated cells. 
 
Figure 5. Effects of the selected non-phototoxic compounds on cell-associated IL-18. NCTC2544 cells were 
irradiated (I) at the UVA dose of 3.5 J/cm
2 
or non-irradiated (NI) in the presence of increasing concentrations 
of the selected non-phototoxic compounds, using the CV80 calculated under irradiated condition as highest 
concentration. Results are expressed as IL-18 SI (I/NI). A dotted line was set at a SI of 1.3. Each data is 
mean ± SD, n= 4. Statistical analysis was performed with Dunnett’s multiple comparison test. 
 
Figure 6. Reproducibility of data. Results obtained in several independent experiments performed over one 
year period are reported. NCTC2544 cells were irradiated (I) at the UVA dose of 3.5 J/cm
2 
or non-irradiated 
(NI) in the presence of chloropromazine 1.25 M (15 experiments), ketoprofen 2.5 M (4 experiments) and 
6-methylcoumarin 10 M (5 experiments). Results are expressed as IL-18 SI (I/NI). A dotted line was set at a 
SI of 1.3. Each dot represents an independent experiment. Mean ± SD is also reported.  
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Highlights 
 Cell-based in vitro test for screening the photosensitizing potential of chemicals 
 Development of a new in vitro method based on IL-18 production in kerartinocytes 
 Overall accuracy 100% was achieved 
*Highlights (for review)
